Valuation: Kaken Pharmaceutical Co., Ltd.

Market Cap 143B 904M 808M 742M 674M 1.27B 85.68B 1.3B 8.86B 3.56B 45.22B 3.39B 3.32B P/E 2027 *
22.8x
P/E 2028 * 46.4x
Enterprise Value 93B 587M 524M 482M 437M 821M 55.59B 842M 5.75B 2.31B 29.34B 2.2B 2.16B EV / Sales 2027 *
1.07x
EV / Sales 2028 * 1.15x
Free-Float
74.5%
Yield 2027 *
5.02%
Yield 2028 * 5.02%
1 day-1.17%
1 week-1.94%
Current month-1.17%
1 month+0.26%
3 months-0.26%
6 months-7.12%
Current year-5.73%
1 week 3,775
Extreme 3775
3,850
1 month 3,700
Extreme 3700
3,920
Current year 3,700
Extreme 3700
4,445
1 year 3,540
Extreme 3540
4,445
3 years 3,161
Extreme 3161
4,901
5 years 3,161
Extreme 3161
4,901
10 years 3,161
Extreme 3161
6,970
Manager TitleAgeSince
President 64 2020-06-25
Chief Tech/Sci/R&D Officer 55 2024-05-31
Chief Tech/Sci/R&D Officer 62 2017-03-31
Director TitleAgeSince
Director/Board Member 64 2016-05-31
Director/Board Member 65 2020-05-31
Director/Board Member 64 2021-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.17%-1.94%+3.27%+12.99% 908M
-0.11%+9.94%+57.20%+148.21% 1,257B
-1.62%-0.95%+42.90%+75.88% 651B
-0.98%-0.14%+34.93%+102.23% 510B
-1.56%-1.39%+51.02%+64.18% 388B
-2.49%+2.01%+75.38%+39.94% 366B
-0.02%+3.15%+32.47%+55.33% 303B
-0.72%+7.05%+10.34%+32.79% 288B
-0.90%+2.97%+55.67%+70.93% 252B
-1.68%+5.27%+37.21%+105.26% 211B
Average -1.07%+3.94%+40.04%+70.77% 422.76B
Weighted average by Cap. -0.71%+5.30%+47.25%+93.13%

Financials

2027 *2028 *
Net sales 86.85B 548M 490M 450M 408M 767M 51.92B 786M 5.37B 2.16B 27.4B 2.06B 2.01B 81.94B 517M 462M 424M 385M 724M 48.98B 742M 5.07B 2.04B 25.85B 1.94B 1.9B
Net income 6.29B 39.67M 35.44M 32.56M 29.57M 55.53M 3.76B 56.92M 389M 156M 1.98B 149M 146M 3.1B 19.53M 17.45M 16.03M 14.56M 27.34M 1.85B 28.03M 191M 76.98M 977M 73.32M 71.75M
Net Debt -50.33B -318M -284M -261M -237M -445M -30.08B -456M -3.11B -1.25B -15.88B -1.19B -1.17B -48.91B -309M -276M -253M -230M -432M -29.23B -443M -3.02B -1.22B -15.43B -1.16B -1.13B
Projected Income Statement - Annual - Kaken Pharmaceutical Co., Ltd.
Logo Kaken Pharmaceutical Co., Ltd.
Kaken Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical and real estate businesses. The Company has two business segments. The Pharmaceutical Business segment is primarily engaged in the manufacture and sale of pharmaceuticals, medical equipment, and agricultural chemicals. The Real Estate Business segment is primarily engaged in the rental of real estate related to Bunkyo Green Court.
Employees
1,114
Date Price Change Volume
26-11-02 JP¥3,785.00 -1.17% 103,400
26-10-30 JP¥3,830.00 +0.79% 88,200
26-10-29 JP¥3,800.00 +0.13% 272,400
26-10-28 JP¥3,795.00 -0.13% 145,500
26-10-27 JP¥3,800.00 -1.55% 118,800
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Kaken Pharmaceutical Co., Ltd.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
3,785.00JPY
Average target price
4,575.00JPY
Spread / Average Target
+20.87%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Kaken Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 4521 Stock